We are testing a new system for linking grants to scientists.
The funding information displayed below comes from the
NIH Research Portfolio Online Reporting Tools and the
NSF Award Database.
The grant data on this page is limited to grants awarded in the United States and is thus partial. It can nonetheless be used to understand how funding patterns influence mentorship networks and vice-versa, which has deep implications on how research is done.
You can help! If you notice any innacuracies, please
sign in and mark grants as correct or incorrect matches.
Sign in to see low-probability grants and correct any errors in linkage between grants and researchers.
High-probability grants
According to our matching algorithm, Bradley W. Schroeder is the likely recipient of the following grants.
Years |
Recipients |
Code |
Title / Keywords |
Matching score |
2003 — 2005 |
Schroeder, Bradley W |
F30Activity Code Description: Individual fellowships for predoctoral training which leads to the combined M.D./Ph.D. degrees. |
Amygdala Synaptic Plasticity in Fear Learning @ University of Texas Medical Br Galveston
DESCRIPTION (provided by applicant): We have recently discovered that the stimulus selectivity for amygdala synaptic potentiation is altered as a result of fear memory formation. A novel form of long-term potentiation that is low-frequency stimulation dependent is revealed, while potentiation that is high-frequency stimulation dependent is attenuated. Other forms of low-frequency stimulation dependent plasticity require activation of group II metabotropic glutamate receptors and antagonists of these receptors within the amygdala block fear conditioning. Here we will test the hypothesis that low frequency induced potentiation is a unique form of plasticity with features that diverge from those previously described in the amygdala by addressing the following specific aims: 1. Analyze the signaling mechanisms underlying the low frequency stimulation-induced long-term potentiation of the cortico-lateral amygdala synapse following fear conditioning and 2. Characterize the role of group II mGluRs in synaptic transmission and on low frequency dependent synaptic plasticity within the cortico-lateral amygdala pathway in control and fear-conditioned animals. These experiments will enhance our understanding of neuronal mechanisms underlying the formation and expression of anxiety and fear and provide valuable insight into potential avenues of treatment for human anxiety disorders.
|
0.984 |
2011 — 2012 |
Schroeder, Bradley W. |
F32Activity Code Description: To provide postdoctoral research training to individuals to broaden their scientific background and extend their potential for research in specified health-related areas. |
Novel Molecules in Airway Epithelial Endoplasmic Reticulum @ University of California, San Francisco
DESCRIPTION (provided by applicant): My career goal is to become an independent physician-scientist investigating basic mechanisms of airway epithelial biology contributing to chronic respiratory diseases. This application outlines a comprehensive training program including an intensive laboratory research experience, a set of courses and seminars, and a mentoring system. The program builds upon my experiences as a neuroscience Ph.D. student and a clinical pulmonary fellow. My research project is inspired by exciting new discoveries made in the lab of my mentor, Dr. David Erle. Excessive amounts of mucins, enormous glycoproteins that appear to be critical for the viscoelastic properties of mucus, contribute to morbidity and mortality in chronic airway diseases such as asthma, COPD, and cystic fibrosis. Previous trainees in the Erle lab have shown that AGR2, a novel member of the protein disulfide isomerase (PDI) family, plays a selective role in mucus production in vivo. Mice lacking AGR2 are completely unable to produce intestinal mucin and have reduced airway mucin production in a mouse model of asthma. I hypothesize that AGR2 and a closely related PDI, AGR3, interact directly with airway mucins in the endoplasmic reticulum and that these interactions are critical for mucin production. AGR proteins may also interact with other proteins as they transit through the ER of mucous cells and perhaps other cells in the lung. I have 3 specific aims: Aim 1 will analyze AGR2, AGR3 and mucin expression patterns in airway epithelium from naove and allergen- challenged mice using immunohistochemistry. Aim 2 will analyze the ability of AGR2 and AGR3 to bind to mucins and other potential binding partners in airway epithelial cells. Aim 3 will analyze the function of AGR2 and AGR3 by knocking down AGR2 and AGR3 in cultured human bronchial epithelial cells. These experiments will enhance our understanding of the basic cellular mechanisms important for airway production of mucins and determine whether AGR2 and AGR3 are promising targets for the treatment of mucus hypersecretion. I will gain valuable hands-on experience in cell culture, animal models of airway disease, molecular biology, and biochemistry. The lab work will be complemented by coursework and state of the art seminars to keep me abreast of recent developments in relevant fields and help me develop skills in writing and oral presentation. A committee comprised of senior pulmonary scientists and an internationally known expert in ER biology will monitor my progress and advise me. This integrated training program will provide me with the experience needed to begin a career as a successful independent investigator. PUBLIC HEALTH RELEVANCE: This proposal will investigate the role of novel proteins in mucus production within the airway. These studies will aid our understanding of the cellular processes underlying excessive mucus production in diseases such as asthma, emphysema, and cystic fibrosis.
|
0.942 |